CKD患者经皮或外科冠脉血运重建后的全因死亡与终末期肾病进展
该研究基于马萨诸塞州2003至2012年接受CABG或PCI的CKD患者数据,链接美国肾脏数据系统,经倾向评分匹配多变量生存模型分析。在3775对匹配患者中,CABG较PCI总体生存改善且ESKD风险降低,但效应受左主干病变和既往心梗修饰。ESKD绝对风险远低于死亡风险,提示临床决策应优先考虑死亡。
要点
- CKD患者CABG后总体生存优于PCI,ESKD风险亦较低。
- 左主干病变无既往心梗者,PCI后生存较CABG差(HR=3.7)。
- 左主干病变伴既往心梗者,PCI后ESKD风险更高(HR=8.1)。
核心结论
- CABG与PCI后的死亡和ESKD风险受左主干病变和既往心梗修饰。
- 左主干病变无既往心梗的CKD患者,CABG后生存优于PCI。
- 左主干病变伴既往心梗的CKD患者,CABG后ESKD风险低于PCI。
- ESKD绝对风险显著低于死亡风险,临床决策应优先考虑死亡。
研究设计与样本
- 马萨诸塞州2003至2012年接受CABG或PCI的CKD居民数据链接美国肾脏数据系统。
- 共识别6805例CABG和17494例PCI患者,经倾向评分匹配形成3775对。
- 采用倾向评分匹配多变量生存模型分析死亡、ESKD及复合终点。
主要发现
- 匹配队列中多支病变占97%,CABG组和PCI组4期CKD分别占11.9%和12.2%。
- 1年死亡(CABG 7.7%,PCI 11.0%)比ESKD(CABG 1.4%,PCI 1.7%)更常见。
- 左主干病变无既往心梗者,PCI较CABG生存更差(HR=3.7,95%CI 1.3-10.5)。
- 左主干病变伴既往心梗者,PCI后ESKD风险更高(HR=8.1,95%CI 1.7-39.2)。
关键数值与推荐
- 左主干病变无既往心梗者PCI vs CABG的死亡HR=3.7(95%CI 1.3-10.5)。
- 左主干病变伴既往心梗者PCI vs CABG的ESKD HR=8.1(95%CI 1.7-39.2)。
- 1年死亡率CABG 7.7%、PCI 11.0%;1年ESKD率CABG 1.4%、PCI 1.7%。
临床怎么用
- CKD患者选择冠脉血运重建方式时,应评估左主干病变和既往心梗。
- 左主干病变无既往心梗的CKD患者,CABG可能带来生存获益。
- 左主干病变伴既往心梗的CKD患者,CABG可能降低ESKD风险。
- 临床决策应优先考虑死亡风险而非ESKD风险。
局限性
- 原文摘要未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Relative impacts of coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) on mortality and end-stage kidney disease (ESKD) in chronic kidney disease (CKD) are uncertain. METHODS: Data from Massachusetts residents with CKD undergoing CABG or PCI from 2003 to 2012 were linked to the United States Renal Data System. Associations with death, ESKD, and combined death and ESKD were analyzed in propensity score-matched multivariable survival models. RESULTS: We identified 6805 CABG and 17,494 PCI patients. Among 3775 matched-pairs, multi-vessel disease was present in 97%, and stage 4 CKD was present in 11.9% of CABG and 12.2% of PCI patients. One-year mortality (CABG 7.7%, PCI 11.0%) was more frequent than ESKD (CABG 1.4%, PCI 1.7%). Overall survival was improved and ESKD risk decreased with CABG compared to PCI, but effects differed in the presence of left main disease and prior myocardial infarction (MI). Survival was worse following PCI than following CABG among patients with left main disease and without MI (hazard ratio = 3.7, 95% confidence interval = 1.3-10.5). ESKD risk was higher with PCI for individuals with left main disease and prior infarction (hazard ratio = 8.1, 95% confidence interval = 1.7-39.2). CONCLUSION: Risks following CABG and PCI were modified by left main disease and prior MI. In individuals with CKD, survival was greater after CABG than after PCI in patients with left main disease but without MI, whereas ESKD risk was lower with CABG in those with left main and MI. Absolute risks of ESKD were markedly lower than for mortality, suggesting prioritizing mortality over ESKD in clinical decision making.
引用
- Charytan DM, Zelevinsky K, Wolf R, et al. All-Cause Mortality and Progression to End-Stage Kidney Disease Following Percutaneous Revascularization or Surgical Coronary Revascularization in Patients with CKD. Kidney Int Rep. 2021. PMID: 34169198. doi:10.1016/j.ekir.2021.03.882
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。